# Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study

> **NCT02050269** · PHASE3 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 100 (actual)

## Conditions studied

- Acute Circulatory Failure

## Interventions

- **DRUG:** Iohexol

## Key facts

- **NCT ID:** NCT02050269
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02050269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02050269, "Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT02050269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*